126 related articles for article (PubMed ID: 36105244)
1. Optimization Method of an Antibreast Cancer Drug Candidate Based on Machine Learning.
Huang Z; Jiang S; Xiao W
Comput Math Methods Med; 2022; 2022():4133663. PubMed ID: 36105244
[TBL] [Abstract][Full Text] [Related]
2. Topology-enhanced molecular graph representation for anti-breast cancer drug selection.
Gao Y; Chen S; Tong J; Fu X
BMC Bioinformatics; 2022 Sep; 23(1):382. PubMed ID: 36123643
[TBL] [Abstract][Full Text] [Related]
3. Optimal modeling of anti-breast cancer candidate drugs screening based on multi-model ensemble learning with imbalanced data.
Zhou J; Li X; Ma Y; Wu Z; Xie Z; Zhang Y; Wei Y
Math Biosci Eng; 2023 Jan; 20(3):5117-5134. PubMed ID: 36896538
[TBL] [Abstract][Full Text] [Related]
4. A computer-aided drug design approach to discover tumour suppressor p53 protein activators for colorectal cancer therapy.
Patrício RPS; Videira PA; Pereira F
Bioorg Med Chem; 2022 Jan; 53():116530. PubMed ID: 34861473
[TBL] [Abstract][Full Text] [Related]
5. Antistroke Network Pharmacological Prediction of Xiaoshuan Tongluo Recipe Based on Drug-Target Interaction Based on Deep Learning.
Zhou Y
Comput Math Methods Med; 2022; 2022():6095964. PubMed ID: 35959347
[TBL] [Abstract][Full Text] [Related]
6. Representation learning for mammography mass lesion classification with convolutional neural networks.
Arevalo J; González FA; Ramos-Pollán R; Oliveira JL; Guevara Lopez MA
Comput Methods Programs Biomed; 2016 Apr; 127():248-57. PubMed ID: 26826901
[TBL] [Abstract][Full Text] [Related]
7. Machine learning prediction of oncology drug targets based on protein and network properties.
Dezső Z; Ceccarelli M
BMC Bioinformatics; 2020 Mar; 21(1):104. PubMed ID: 32171238
[TBL] [Abstract][Full Text] [Related]
8. Combining handcrafted features with latent variables in machine learning for prediction of radiation-induced lung damage.
Cui S; Luo Y; Tseng HH; Ten Haken RK; El Naqa I
Med Phys; 2019 May; 46(5):2497-2511. PubMed ID: 30891794
[TBL] [Abstract][Full Text] [Related]
9. Application of random forest based on semi-automatic parameter adjustment for optimization of anti-breast cancer drugs.
Liu J; Zhou Z; Kong S; Ma Z
Front Oncol; 2022; 12():956705. PubMed ID: 35936743
[TBL] [Abstract][Full Text] [Related]
10. Diabetes mellitus prediction and diagnosis from a data preprocessing and machine learning perspective.
Olisah CC; Smith L; Smith M
Comput Methods Programs Biomed; 2022 Jun; 220():106773. PubMed ID: 35429810
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided breast MR image feature analysis for prediction of tumor response to chemotherapy.
Aghaei F; Tan M; Hollingsworth AB; Qian W; Liu H; Zheng B
Med Phys; 2015 Nov; 42(11):6520-8. PubMed ID: 26520742
[TBL] [Abstract][Full Text] [Related]
12. Error Tolerance of Machine Learning Algorithms across Contemporary Biological Targets.
Kaiser TM; Burger PB
Molecules; 2019 Jun; 24(11):. PubMed ID: 31167452
[TBL] [Abstract][Full Text] [Related]
13. Artificial immune system features added to breast cancer clinical data for machine learning (ML) applications.
Nave O; Elbaz M
Biosystems; 2021 Apr; 202():104341. PubMed ID: 33482276
[TBL] [Abstract][Full Text] [Related]
14. A deep neural network-based approach for prediction of mutagenicity of compounds.
Kumar R; Khan FU; Sharma A; Siddiqui MH; Aziz IB; Kamal MA; Ashraf GM; Alghamdi BS; Uddin MS
Environ Sci Pollut Res Int; 2021 Sep; 28(34):47641-47650. PubMed ID: 33895950
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Blood-Brain Barrier Penetration (BBBP) Based on Molecular Descriptors of the Free-Form and In-Blood-Form Datasets.
Sakiyama H; Fukuda M; Okuno T
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946509
[TBL] [Abstract][Full Text] [Related]
16. An effective up-sampling approach for breast cancer prediction with imbalanced data: A machine learning model-based comparative analysis.
Tran T; Le U; Shi Y
PLoS One; 2022; 17(5):e0269135. PubMed ID: 35622821
[TBL] [Abstract][Full Text] [Related]
17. Radiomic machine learning for predicting prognostic biomarkers and molecular subtypes of breast cancer using tumor heterogeneity and angiogenesis properties on MRI.
Lee JY; Lee KS; Seo BK; Cho KR; Woo OH; Song SE; Kim EK; Lee HY; Kim JS; Cha J
Eur Radiol; 2022 Jan; 32(1):650-660. PubMed ID: 34226990
[TBL] [Abstract][Full Text] [Related]
18. Predicting Breast Cancer Leveraging Supervised Machine Learning Techniques.
Aamir S; Rahim A; Aamir Z; Abbasi SF; Khan MS; Alhaisoni M; Khan MA; Khan K; Ahmad J
Comput Math Methods Med; 2022; 2022():5869529. PubMed ID: 36017156
[TBL] [Abstract][Full Text] [Related]
19. Machine learning models in breast cancer survival prediction.
Montazeri M; Montazeri M; Montazeri M; Beigzadeh A
Technol Health Care; 2016; 24(1):31-42. PubMed ID: 26409558
[TBL] [Abstract][Full Text] [Related]
20. Optimizing neural networks for medical data sets: A case study on neonatal apnea prediction.
Shirwaikar RD; Acharya U D; Makkithaya K; M S; Srivastava S; Lewis U LES
Artif Intell Med; 2019 Jul; 98():59-76. PubMed ID: 31521253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
